Computationally Identified Novel Diphenyl- and Phenylpyridine Androgen Receptor Antagonist Structures

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Chemical Information and Modeling

• Publication date

  2008-08-20

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1021/ci800149wPMID 18712859
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alien interacts with the human androgen receptor and inhibits prostate cancer cell growth.

  2007cited by this paper
• Crystal Structure of the T877A Human Androgen Receptor Ligand-binding Domain Complexed to Cyproterone Acetate Provides Insight for Ligand-induced Conformational Changes and Structure-based Drug Design*

  2007cited by this paper
• Structural Characterization of the Human Androgen Receptor Ligand-binding Domain Complexed with EM5744, a Rationally Designed Steroidal Ligand Bearing a Bulky Chain Directed toward Helix 12*

  2007cited by this paper
• A critical assessment of docking programs and scoring functions.

  2006cited by this paper
• Non-steroidal steroid receptor modulators.

  2006cited by this paper
• Pharmacokinetics and Pharmacodynamics of Nonsteroidal Androgen Receptor Ligands

  2006cited by this paper
• Free energy simulations of uncatalyzed DNA replication fidelity: structure and stability of T.G and dTTP.G terminal DNA mismatches flanked by a single dangling nucleotide.

  2006cited by this paper
• Role of crystal-amorphous interaction in phase equilibria of crystal-amorphous polymer blends.

  2006cited by this paper
• Novel procedure for modeling ligand/receptor induced fit effects.

  2006cited by this paper
• Non-steroidal steroid receptor modulators.

  2005cited by this paper
• The Androgen Receptor Recruits Nuclear Receptor CoRepressor (N-CoR) in the Presence of Mifepristone via Its N and C Termini Revealing a Novel Molecular Mechanism for Androgen Receptor Antagonists*

  2005cited by this paper
• Structural basis for antagonism and resistance of bicalutamide in prostate cancer

  2005cited by this paper
• An Extensive Test for 14 Scoring Functions Using the PDBbind Refined Set of 800 Protein—Ligand Complexes.

  2005cited by this paper
• Structure based approach to the design of bicyclic-1H-isoindole-1,3(2H)-dione based androgen receptor antagonists.

  2005cited by this paper
• Computer simulations of protein functions: searching for the molecular origin of the replication fidelity of DNA polymerases.

  2005cited by this paper
• Three-dimensional structure-activity relationships of nonsteroidal ligands in complex with androgen receptor ligand-binding domain.

  2005cited by this paper
• Chemistry and structural biology of androgen receptor.

  2005cited by this paper
• Antiandrogens prevent stable DNA-binding of the androgen receptor

  2005cited by this paper
• Chemistry and Structural Biology of Androgen Receptor

  2005cited by this paper
• Structural Basis for Accommodation of Nonsteroidal Ligands in the Androgen Receptor*

  2005cited by this paper
• An Extensive Test of 14 Scoring Functions Using the PDBbind Refined Set of 800 Protein-Ligand Complexes

  2004cited by this paper
• The highly conserved region of the co-repressor Sin3A functionally interacts with the co-repressor Alien.

  2004cited by this paper
• Mechanism of the nuclear receptor molecular switch.

  2004cited by this paper
• The androgen receptor gene mutations database (ARDB): 2004 update

  2004cited by this paper
• Comparative evaluation of 11 scoring functions for molecular docking.

  2003cited by this paper
• Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.

  2003cited by this paper
• Bicalutamide Functions as an Androgen Receptor Antagonist by Assembly of a Transcriptionally Inactive Receptor*

  2002cited by this paper
• The amino terminus of the human AR is target for corepressor action and antihormone agonism.

  2002cited by this paper
• Human cell lines engineered for tetracycline‐regulated expression of tumor suppressor candidate genes from a frequently affected chromosomal region, 3p21

  2002cited by this paper
• Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone

  2001cited by this paper
• The Protein Data Bank

  2000cited by this paper
• Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications.

  2000cited by this paper
• Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist.

  1999cited by this paper
• The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.

  1998cited by this paper
• Development and validation of a genetic algorithm for flexible docking.

  1997cited by this paper
• A signature motif in transcriptional co-activators mediates binding to nuclear receptors

  1997cited by this paper
• Molecular basis of agonism and antagonism in the oestrogen receptor

  1997cited by this paper
• The androgen receptor gene mutations database.

  1994cited by this paper
• Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

  1994cited by this paper
• FROM ATOMS AND BONDS TO THREE-DIMENSIONAL ATOMIC COORDINATES : AUTOMATIC MODEL BUILDERS

  1993cited by this paper
• Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation.

  1992cited by this paper
• A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens.

  1990cited by this paper
• Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.

  1988cited by this paper
• Electronic Reprint Biological Crystallography the Protein Data Bank Biological Crystallography the Protein Data Bank

  year unknowncited by this paper

• Drug-like molecules targeting androgen receptor's allosteric binding sites selected by augmented AI and high-throughput screening as antitumor agents against prostate cancer.

  2025cites this paper
• Screening androgen receptor agonists of fish species using machine learning and molecular model in NORMAN water-relevant list.

  2024cites this paper
• Guidance for the identification of endocrine disruptors in the context of Regulations (EU) No 528/2012 and (EC) No 1107/2009

  2018cites this paper
• Iminoenamine based novel androgen receptor antagonist exhibited anti-prostate cancer activity in androgen independent prostate cancer cells through inhibition of AKT pathway.

  2017cites this paper
• Discovery of novel androgen receptor antagonists: a hybrid approach of pharmacophore-based and docking-based virtual screening

  2015cites this paper
• Applications of Molecular Modeling in Endocrinology- Review Article

  2014cites this paper
• Application of fluorine-containing non-steroidal anti-androgen compounds in treating prostate cancer

  2014cites this paper
• Structure-based Virtual Screening and Identification of a Novel Androgen Receptor Antagonist*

  2012cites this paper
• Identification and Characterization of MEL-3, a Novel AR Antagonist That Suppresses Prostate Cancer Cell Growth

  2012cites this paper
• Steroids with inhibitory activity against the prostate cancer cells and chemical diversity of marine alga Tydemania expeditionis.

  2012cites this paper
• Therapeutic Discovery Identi fi cation and Characterization of MEL-3 , a Novel AR Antagonist That Suppresses Prostate Cancer Cell Growth

  2012cites this paper
• Synthesis of Substituted 2,6-Dicyanoanilines and Related Compounds. A Review

  2012cites this paper
• Multi-target drug discovery in anti-cancer therapy: fragment-based approach toward the design of potent and versatile anti-prostate cancer agents.

  2011cites this paper
• Mining Natural Product-Derived Molecules Against Cancer Targets: The Case of the Androgen Receptor in Prostate Cancer

  2010cites this paper
• Computational studies of interactions between endocrine disrupting chemicals and androgen receptor of different vertebrate species.

  2010cites this paper
• Review of QSAR Models and Software Tools for predicting Developmental and Reproductive Toxicity

  2010cites this paper
• Developments in Nonsteroidal Antiandrogens Targeting the Androgen Receptor

  2010cites this paper
• Prospective ligand- and target-based 3D QSAR: state of the art 2008.

  2009cites this paper
• Neue Inhibitoren der Proteinkinasen PfGSK-3 und RET

  2009cites this paper